S&P 5007,713▲ 0.28%Nasdaq26,425▼ 0.02%Dow Jones52,496▲ 1.02%Nasdaq 10029,490▼ 0.13%VIX17.31▼ 6.13%US Dollar101.73▼ 0.25%Gold spot4,145▲ 0.30%WTI spot101.91▲ 1.04%
Home › PLT › Research report
← PLT page
XStocksXray
Market X-Ray report · 20 October 2026

Plenti Group Ltd (PLT)

Australian Securities Exchange · Australia · prices in AUD · close of 20 Oct 2026

Key indicators

Last closeAUD 0.685
52-week range0.663 – 1.520
Return, 1 month / 3 months−6.2% / −11.0%
Return, 1 year / 3 years−51.9% / +95.7%
TrendBelow its 200-day average
RSI (14)32
Volatility (1 year)48.0%
Worst drawdown (1 year)-55.0%
Average daily value traded0.08M AUD
Dividend yield–

Market X-Ray price-based

47/ 100 · High confidence · ahead of 46% of stocks on this exchange
Trend40
Momentum34
Stability (higher is calmer)60
Liquidity59
Income–

Five-year price chart navy: price · brown: 200-day average

0.250.610.961.321.672021-102023-012024-042025-072026-10

About the company

Plenti Group is an Australian financial technology lender based in Sydney. It provides consumer loans for vehicles and other personal needs, along with financing for renewable energy and home improvements. The company also runs an investment platform that lets retail investors put money into the loans it originates. Its customers are individual borrowers across Australia and the investors who fund those loans through its online marketplace.

The shares are listed on the Australian Securities Exchange in Australia under the code PLT, and the price on this page is in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Plenti Group Ltd (PLT) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.685 on 20 October 2026.

Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 987 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 51.9% and over the last three months it fell 11.0%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Plenti Group Ltd (PLT)

The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange

Lens and metricValueScoreReading
Trend40 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-19.3%
From 52-week high-54.3%
Momentum34 · WeakLagging most stocks on this exchange.
3-month return-11.0%
6-month return-23.5%
12-month return, skipping the last month-48.8%
Stability (higher is calmer)60 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)48.0%
Worst drawdown, 1 year (smaller is calmer)-55.0%
Liquidity59 · FairModerate trading activity.
Average daily value traded0.08M AUD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.

Returns

1 week−4.9%
1 month−6.2%
3 months−11.0%
6 months−23.5%
1 year−51.9%
3 years+95.7%
5 years−49.6%

Signals

50-day / 200-day average0.776 / 0.849
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.024

Technical summary

DailyStrongly bearish3 bullish · 1 neutral · 12 bearish
WeeklyStrongly bearish0 bullish · 1 neutral · 11 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 21 Oct 2026